With reference to email Ref no. L/SURV/ONL/PV/NJ/2021-2022/20 dated April 22, 2021 dated April 22, 2021 seeking clarification on significant increase in the volume of security across Exchanges in the recent past, RPG Life Sciences has informed that there are no events, information, announcements etc that have a bearing on the operations/ performance of the Company which includes price sensitive information, which is required to be disclosed to the stock exchanges pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Hence, the Company is unable to comment on the significant increase in the volume of Company’s security across Exchanges, in the recent past. Further, the Company reiterated that, as in the past, the Company would continue to inform stock exchanges regularly about any price sensitive information and to make it available on the website of the Company before the same is made public.
The above information is a part of company’s filings submitted to BSE.
